Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Liu David Y
Chief Scientific Officer at Protagonist Therapeutics. Filing since 10 Jul 2017.
CIK 0001675881
Company
Date
Role
Action
Shares
Amount
Of holding
PTGX
Protagonist Therapeutics, Inc
17 Aug 2021
Chief Scientific Officer
Sold, plan not stated
14,779
$702.89K
20.2%
PTGX
Protagonist Therapeutics, Inc
6 Aug 2019
Chief Scientific Officer
Sold, plan not stated
3,395
$30.04K
6.4%
PTGX
Protagonist Therapeutics, Inc
1 Mar 2019
Chief Scientific Officer
Sold, plan not stated
810
$6.50K
1.6%
PTGX
Protagonist Therapeutics, Inc
6 Feb 2019
Chief Scientific Officer
Sold, plan not stated
3,821
$29.56K
9.4%
PTGX
Protagonist Therapeutics, Inc
12 Mar 2018
Chief Scientific Officer
Sold, plan not stated
3,500
$74.50K
18.9%
PTGX
Protagonist Therapeutics, Inc
2 Mar 2018
Chief Scientific Officer
Sold, plan not stated
875
$17.50K
6.2%
PTGX
Protagonist Therapeutics, Inc
16 Jan 2018
Chief Scientific Officer
Sold, plan not stated
875
$17.50K
18.6%
PTGX
Protagonist Therapeutics, Inc
18 Dec 2017
Chief Scientific Officer
Sold, plan not stated
875
$17.50K
18.6%
PTGX
Protagonist Therapeutics, Inc
30 Nov 2017
Chief Scientific Officer
Sold, plan not stated
875
$17.50K
18.6%
PTGX
Protagonist Therapeutics, Inc
13 Nov 2017
Chief Scientific Officer
Sold, plan not stated
7,000
$118.76K
64.7%
PTGX
Protagonist Therapeutics, Inc
28 Aug 2017
Chief Scientific Officer
Sold, plan not stated
3,500
$52.50K
63.6%
PTGX
Protagonist Therapeutics, Inc
10 Jul 2017
Chief Scientific Officer
Sold, plan not stated
3,500
$44.38K
63.6%
12 decisions on file.
